Sponsored
Sponsored
Media Summary: Some $3 billion is the estimated amount of federal funds left unspent this past year, after the Trump Administration froze or ... In an exclusive interview, MSNBC's Ari Melber is joined by So mRNA technology is what we've been working on at

Moderna Co Founder Science Cuts - Detailed Analysis & Overview

Some $3 billion is the estimated amount of federal funds left unspent this past year, after the Trump Administration froze or ... In an exclusive interview, MSNBC's Ari Melber is joined by So mRNA technology is what we've been working on at CNBC's Meg Tirrell joins 'Squawk Box' to report on shares of

Photo Gallery

Moderna Co-Founder: Science Cuts Could Lead to “Dystopian Future” | Amanpour and Company
Moderna Co-founder on Federal Cuts to Research
Moderna Co-founder on Impact of Cuts to Vaccine Research
Moderna CEO explains why the company is going to cut $1.1 billion in costs by 2027
Moderna misses in Q3, cuts forecast for COVID vaccine revenue
Moderna co-founder talks COVID-19 vaccines, mRNA growth, agriculture portfolio
Moderna cuts COVID-19 vaccine sales forecast
AstraZeneca Shot Speculation 'Not Helpful': Moderna Co-founder
Moderna Co-Founder Explains Vaccine Distribution Plan | Amanpour and Company
BVTV: Moderna’s $94 billion hope
Digital@Moderna: Creating the Next Generation of Life Science
Moderna Co-founder on Boosters Against Variant Strains
View Detailed Profile
Moderna Co-Founder: Science Cuts Could Lead to “Dystopian Future” | Amanpour and Company

Moderna Co-Founder: Science Cuts Could Lead to “Dystopian Future” | Amanpour and Company

Some $3 billion is the estimated amount of federal funds left unspent this past year, after the Trump Administration froze or ...

Moderna Co-founder on Federal Cuts to Research

Moderna Co-founder on Federal Cuts to Research

Noubar Afeyan,

Sponsored
Moderna Co-founder on Impact of Cuts to Vaccine Research

Moderna Co-founder on Impact of Cuts to Vaccine Research

Noubar Afeyan,

Moderna CEO explains why the company is going to cut $1.1 billion in costs by 2027

Moderna CEO explains why the company is going to cut $1.1 billion in costs by 2027

Moderna CEO

Moderna misses in Q3, cuts forecast for COVID vaccine revenue

Moderna misses in Q3, cuts forecast for COVID vaccine revenue

Moderna

Sponsored
Moderna co-founder talks COVID-19 vaccines, mRNA growth, agriculture portfolio

Moderna co-founder talks COVID-19 vaccines, mRNA growth, agriculture portfolio

Moderna

Moderna cuts COVID-19 vaccine sales forecast

Moderna cuts COVID-19 vaccine sales forecast

Moderna cut

AstraZeneca Shot Speculation 'Not Helpful': Moderna Co-founder

AstraZeneca Shot Speculation 'Not Helpful': Moderna Co-founder

Mar.15 -- Noubar Afeyan,

Moderna Co-Founder Explains Vaccine Distribution Plan | Amanpour and Company

Moderna Co-Founder Explains Vaccine Distribution Plan | Amanpour and Company

Noubar Afeyan,

BVTV: Moderna’s $94 billion hope

BVTV: Moderna’s $94 billion hope

Moderna

Digital@Moderna: Creating the Next Generation of Life Science

Digital@Moderna: Creating the Next Generation of Life Science

The team that created

Moderna Co-founder on Boosters Against Variant Strains

Moderna Co-founder on Boosters Against Variant Strains

May.05 --

Moderna Co-Founder: “[Vaccine] Supplies Are Ready To Go Out the Door” | Amanpour and Company

Moderna Co-Founder: “[Vaccine] Supplies Are Ready To Go Out the Door” | Amanpour and Company

... Walter Isaacson speaks with

Moderna Co-Founder On New Vaccines And Profiting During The Pandemic | The Beat With Ari Melber

Moderna Co-Founder On New Vaccines And Profiting During The Pandemic | The Beat With Ari Melber

In an exclusive interview, MSNBC's Ari Melber is joined by

Coronavirus: Moderna CEO on the promising preliminary results of early-stage study

Coronavirus: Moderna CEO on the promising preliminary results of early-stage study

Moderna's

Moderna Co-Founder: New Normal Can Be Reached As Soon As Late Summer | The Beat With Ari Melber

Moderna Co-Founder: New Normal Can Be Reached As Soon As Late Summer | The Beat With Ari Melber

... MSNBC on Instagram: http://on.msnbc.com/Instamsnbc #Coronavirus #

Moderna co-founder on whether we will need a third COVID-19 shot

Moderna co-founder on whether we will need a third COVID-19 shot

Moderna co

The power of mRNA technology and its potential to impact global public health

The power of mRNA technology and its potential to impact global public health

So mRNA technology is what we've been working on at

Moderna CEO Stephane Bancel on the outlook for the extending timeline of mRNA technology efficacy

Moderna CEO Stephane Bancel on the outlook for the extending timeline of mRNA technology efficacy

MRNAvaccine #

Moderna shares drop after company cuts Covid-19 vaccine outlook

Moderna shares drop after company cuts Covid-19 vaccine outlook

CNBC's Meg Tirrell joins 'Squawk Box' to report on shares of

Related Video Content

Moderna - Wikipedia information

Moderna, Inc. (/ məˈdɜːrnə / mə-DUR-nə) [4] is an American pharmaceutical and biotechnology company based in...

Moderna information

The authorization or approval status of the Moderna COVID 19 Vaccine (also known as COVID-19 Vaccine Moderna) varies...

Moderna, Inc. (MRNA) Stock Price, News, Quote & History - Yahoo … information

Find the latest Moderna, Inc. (MRNA) stock quote, history, news and other vital information to help you with your...

Moderna | History, Innovation, Challenges, & Facts | Britannica Money information

May 17, 2026 · Moderna, Inc. is a biotechnology company specializing in messenger RNA (mRNA) medicines and is best...

Moderna Reports First Quarter 2026 Financial Results and Provides ... information

May 1, 2026 · CAMBRIDGE, MA / ACCESS Newswire / May 1, 2026 / Moderna, Inc. (NASDAQ:MRNA) today reported financial...

Sponsored